PMID- 18339317 OWN - NLM STAT- MEDLINE DCOM- 20080731 LR - 20080506 IS - 0009-8981 (Print) IS - 0009-8981 (Linking) VI - 392 IP - 1-2 DP - 2008 Jun TI - Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure. PG - 17-20 LID - 10.1016/j.cca.2008.02.013 [doi] AB - BACKGROUND: Inflammation plays a pathogenic role in the development of chronic heart failure (CHF). Increasing evidence shows that CD40-CD40 ligand (CD40L) interaction plays a pathogenic role in inflammatory disorders. We assessed whether CD40 ligand expression was abnormal in patients with CHF. METHODS: Twenty normal controls and 86 patients with CHF were investigated. The expression of CD40L on platelets was analyzed by indirect-immunofluorescence flow cytometry, and the soluble CD40L (sCD40L) level was determined by a commercially available enzyme-linked immunosorbent assay (ELISA). B type natriuretic peptide (BNP) was measured by radioimmunoassay. RESULTS: All patients with CHF showed a significant increased expression of CD40L (32.3+/-13.9 MFI) on platelets and sCD40L levels (20.5+/-8.6 microg/l) compared with controls(p<0.0001). CD40L expression on platelets and sCD40L levels positively correlated with New York Heart Association (NYHA) functional class, left ventricular ejection fraction and BNP levels in CHF. CONCLUSIONS: Patients with CHF showed increased expression of CD40L system, which may create a pathogenic role in the development and progression of CHF. FAU - Yan, Jin-Chuan AU - Yan JC AD - Department of Cardiology, Affiliated Hospital of JiangSu University, Zhenjiang 212001, China. yanjinchuan@hotmail.com FAU - Liu, Pei-Jing AU - Liu PJ FAU - Du, Rong-Zeng AU - Du RZ FAU - Liang, Yi AU - Liang Y FAU - Ma, Gen-Shan AU - Ma GS FAU - Zhu, Jian AU - Zhu J FAU - Luo, Dan AU - Luo D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080216 PL - Netherlands TA - Clin Chim Acta JT - Clinica chimica acta; international journal of clinical chemistry JID - 1302422 RN - 114471-18-0 (Natriuretic Peptide, Brain) RN - 147205-72-9 (CD40 Ligand) SB - IM MH - Aged MH - Blood Platelets/immunology/*metabolism MH - CD40 Ligand/*blood/immunology MH - Chronic Disease MH - Female MH - Heart Failure/*blood/immunology MH - Humans MH - Inflammation/immunology MH - Male MH - Middle Aged MH - Natriuretic Peptide, Brain/*blood MH - Platelet Activation MH - Stroke Volume/physiology EDAT- 2008/03/15 09:00 MHDA- 2008/08/01 09:00 CRDT- 2008/03/15 09:00 PHST- 2007/10/28 00:00 [received] PHST- 2008/02/12 00:00 [revised] PHST- 2008/02/12 00:00 [accepted] PHST- 2008/03/15 09:00 [pubmed] PHST- 2008/08/01 09:00 [medline] PHST- 2008/03/15 09:00 [entrez] AID - S0009-8981(08)00078-8 [pii] AID - 10.1016/j.cca.2008.02.013 [doi] PST - ppublish SO - Clin Chim Acta. 2008 Jun;392(1-2):17-20. doi: 10.1016/j.cca.2008.02.013. Epub 2008 Feb 16.